These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10023128)

  • 1. Perils and pitfalls in the interpretation of clinical trials: a reflection on the recent experience in multiple sclerosis.
    Goodin DS
    Neuroepidemiology; 1999; 18(2):53-63. PubMed ID: 10023128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cladribine as a therapeutic option in multiple sclerosis.
    Warnke C; Leussink VI; Goebels N; Aktas O; Boyko A; Kieseier BC; Hartung HP
    Clin Immunol; 2012 Jan; 142(1):68-75. PubMed ID: 21733757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of oral therapies for multiple sclerosis--fingolimod, cladribine and other drugs].
    Hecht B
    Med Monatsschr Pharm; 2010 Apr; 33(4):120-30; quiz 131-2. PubMed ID: 20429402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cladribine: limited evaluation in multiple sclerosis.
    Prescrire Int; 2011; 20(118):175. PubMed ID: 21751748
    [No Abstract]   [Full Text] [Related]  

  • 5. The cladribine trial in secondary progressive MS: response.
    Goodin DS
    Neuroepidemiology; 2000; 19(1):53-4. PubMed ID: 10654289
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic approaches to secondary progressive multiple sclerosis.
    Lublin FD
    Mult Scler; 2002 Feb; 8(1):88-90. PubMed ID: 11936495
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.
    Pula JH; Javed A
    Curr Opin Ophthalmol; 2009 Nov; 20(6):476-81. PubMed ID: 19816177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming multiple sclerosis trials into practical reality.
    Kieseier BC; Wiendl H
    Lancet Neurol; 2011 Jun; 10(6):493-4. PubMed ID: 21571592
    [No Abstract]   [Full Text] [Related]  

  • 9. Cladribine for multiple sclerosis: review and current status.
    Sipe JC
    Expert Rev Neurother; 2005 Nov; 5(6):721-7. PubMed ID: 16274330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of cladribine treatment in multiple sclerosis.
    Sipe JC; Romine JS; Koziol JA; McMillan R; Zyroff J; Beutler E
    Mult Scler; 1996 Jul; 1(6):343-7. PubMed ID: 9345414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressants and multiple sclerosis].
    Ruiz-Peña JL; Izquierdo-Ayuso G
    Rev Neurol; 2002 Aug 16-31; 35(4):373-80. PubMed ID: 12235571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cladribine trial in secondary progressive multiple sclerosis: A reanalysis.
    Beutler E; Koziol JA
    Neuroepidemiology; 2000; 19(2):109-12. PubMed ID: 10686535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined therapy in multiple sclerosis].
    García-Merino JA; Blasco-Quítez MR; Ortiz-Benítez P; Puerta C
    Rev Neurol; 2003 Mar 16-31; 36(6):545-9. PubMed ID: 12652419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current treatment of multiple sclerosis].
    Csépány T
    Lege Artis Med; 2011 Feb; 21(2):97-104. PubMed ID: 21710707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cladribine: mode of action and implications for treatment of multiple sclerosis.
    Leist TP; Weissert R
    Clin Neuropharmacol; 2011; 34(1):28-35. PubMed ID: 21242742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optic neuritis.
    Dorfman L
    N Engl J Med; 2006 Jul; 355(2):212; author reply 212. PubMed ID: 16837690
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of multiple sclerosis: current trials and future options.
    Noseworthy JH
    Curr Opin Neurol; 2003 Jun; 16(3):289-97. PubMed ID: 12858064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta.
    McDonald WI; Miller DH; Thompson AJ
    Ann Neurol; 1994 Jul; 36(1):14-8. PubMed ID: 8024255
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.
    Goodkin DE
    West J Med; 1994 Sep; 161(3):292-8. PubMed ID: 7975569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis.
    Gout O
    Ann Neurol; 2008 Jan; 63(1):126; author reply 126-7. PubMed ID: 17702028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.